In a new clinical practice guideline, recommendations are presented to optimize the use of biologic agents for severe asthma in adults.

The man's family later sued OptumRx and Walgreens, claiming they didn't offer alternatives after his regular inhaler's price ...

The American College of Chest Physicians ® (CHEST) recently released a new clinical guideline on biologic management in severe asthma. Published in the journal CHEST ® , the guideline contains seven ...

Asthma may not be driven by the molecules scientists have blamed for decades. Researchers have identified “pseudo leukotrienes,” inflammation-triggering compounds formed by uncontrolled free-radical ...

Please provide your email address to receive an email when new articles are posted on . The questionnaire assessed general fatigue, sleep-rest fatigue and cognitive fatigue. Asthma-related quality of ...

A monthly injection for managing severe asthma could help patients safely reduce or even discontinue daily steroid ...

The FDA has approved GSK’s Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for severe asthma with an eosinophilic phenotype in patients ages 12 and older. The approval is based on data ...

Blood eosinophil count and fractional exhaled nitric oxide (FeNO) play an important role in selecting biological therapies for severe asthma. This analysis of patient-level data pooled across 22 ...

Rochester, Minn.-based Mayo Clinic researchers have developed AI tools to help identify young children at highest risk for severe asthma and acute respiratory infections. The tools use machine ...

Bronchial thermoplasty (BT) is an innovative bronchoscopic intervention for patients with severe asthma, particularly those who remain symptomatic despite maximised pharmacotherapy. The procedure ...

Please provide your email address to receive an email when new articles are posted on . Data on marijuana’s impact on asthma are unclear. 3.2% of patients with an acute asthma exacerbation reported ...

As-needed use of a metered-dose inhaler with albuterol plus budesonide (Airsupra) lowered the risk of severe exacerbations compared with albuterol alone for people with normally mild asthma, the phase ...